Adagene Inc.

Îles Caïmanes

 
Quantité totale PI 39
Rang # Quantité totale PI 36 005
Note d'activité PI 2,2/5.0    23
Rang # Activité PI 35 068

Brevets

Marques

15 0
9 0
15 0
0
 
Dernier brevet 2024 - Dynamic human heavy chain antibo...
Premier brevet 2013 - An integrated system for library...

Derniers inventions, produits et services

2023 Invention Anti-ctla4 antibodies and methods of making and using the same. Provided herein are cross-reacti...
Invention Dynamic human heavy chain antibody libraries. Provided herein are libraries containing polynucle...
Invention Activatable antibodies and methods of making and using thereof. Provided herein are libraries co...
Invention Dynamic human antibody light chain libraries. Provided herein are libraries containing polynucle...
2022 Invention Combination therapies for treating cancer. Provided herein are compositions and methods for trea...
Invention Combination therapies for treating cancer. Provided herein are compositions and methods for treat...
2021 Invention Anti-cd137 molecules and use thereof. The present disclosure provides antibodies that bind to hu...
2020 Invention Anti-cd137l antibodies and methods of using same. Provided herein are antibodies that bind to an ...
2019 Invention Anti-pd-l1 antibodies and use thereof. The present disclosure provides antibodies that bind to th...
Invention Masked activatable cd137 antibodies. Provided herein are libraries containing synthetic polynucle...
Invention Anti-ctla4 antibodies and methods of making and using the same. Provided herein are cross-reactiv...
Invention Activatable antibodies and methods of making and using thereof. Provided herein are libraries con...
Invention Activatable antibodies and methods of making and using thereof. CA 3090027 2020-07-29 (12) INTERN...
Invention Precision/context-dependent activatable antibodies, and methods of making and using the same. Pr...
2018 Invention Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody. Provided h...
Invention Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody. Provided he...
Invention Method for treating cancer using anti-cd137 antibody. Provided are antibodies that bind to human ...
Invention Anti-cd137 molecules and use thereof. Provided are antibodies that bind to human CD137 or antigen...
Invention Precision/context-dependent activatable antibodies, and methods of making and using the same. Pro...
2017 Invention Methods for using cd137 ligand as biomarker for treatment with anti-cd137 antibody. Provided here...
Invention Dynamic human antibody light chain libraries. Provided herein are libraries containing polynucleo...
Invention Dynamic human heavy chain antibody libraries. Provided herein are libraries containing polynucleo...
Invention Anti-cd137 molecules and use thereof. The present disclosure provides antibodies that bind to hum...
2014 Invention Methods and systems for autoinduction of protein expression. Methods and systems for autoinductio...
2013 Invention An integrated system for library construction, affinity binder screening and expression thereof. ...